nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Toremifene—breast cancer	0.363	0.614	CrCtD
Doxylamine—Tamoxifen—breast cancer	0.228	0.386	CrCtD
Doxylamine—Tamoxifen—Toremifene—breast cancer	0.028	0.088	CrCrCtD
Doxylamine—Toremifene—Tamoxifen—breast cancer	0.0256	0.0805	CrCrCtD
Doxylamine—Dextropropoxyphene—Toremifene—breast cancer	0.0222	0.0699	CrCrCtD
Doxylamine—Bromodiphenhydramine—Toremifene—breast cancer	0.0198	0.0622	CrCrCtD
Doxylamine—Levomethadyl Acetate—Tamoxifen—breast cancer	0.017	0.0535	CrCrCtD
Doxylamine—Methadyl Acetate—Tamoxifen—breast cancer	0.017	0.0535	CrCrCtD
Doxylamine—Clofedanol—Toremifene—breast cancer	0.0161	0.0505	CrCrCtD
Doxylamine—Cyclobenzaprine—Tamoxifen—breast cancer	0.016	0.0503	CrCrCtD
Doxylamine—Orphenadrine—Toremifene—breast cancer	0.0156	0.0489	CrCrCtD
Doxylamine—Benzphetamine—Toremifene—breast cancer	0.0156	0.0489	CrCrCtD
Doxylamine—Dextropropoxyphene—Tamoxifen—breast cancer	0.014	0.0439	CrCrCtD
Doxylamine—Diphenhydramine—Toremifene—breast cancer	0.0138	0.0434	CrCrCtD
Doxylamine—Tripelennamine—Tamoxifen—breast cancer	0.0133	0.0418	CrCrCtD
Doxylamine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0124	0.0391	CrCrCtD
Doxylamine—Dimetacrine—Tamoxifen—breast cancer	0.0124	0.0391	CrCrCtD
Doxylamine—Methadone—Tamoxifen—breast cancer	0.0117	0.0367	CrCrCtD
Doxylamine—Clofedanol—Tamoxifen—breast cancer	0.0101	0.0317	CrCrCtD
Doxylamine—Benzphetamine—Tamoxifen—breast cancer	0.00977	0.0307	CrCrCtD
Doxylamine—Orphenadrine—Tamoxifen—breast cancer	0.00977	0.0307	CrCrCtD
Doxylamine—Promazine—Tamoxifen—breast cancer	0.00933	0.0293	CrCrCtD
Doxylamine—Diphenhydramine—Tamoxifen—breast cancer	0.00868	0.0273	CrCrCtD
Doxylamine—Tamoxifen—ESRRA—breast cancer	0.00026	0.112	CrCbGaD
Doxylamine—Dimetacrine—ACHE—breast cancer	0.000209	0.0901	CrCbGaD
Doxylamine—Tamoxifen—SULT1A1—breast cancer	0.000197	0.0849	CrCbGaD
Doxylamine—Toremifene—ESR1—breast cancer	8.55e-05	0.0368	CrCbGaD
Doxylamine—Toremifene—CYP1A1—breast cancer	6.83e-05	0.0295	CrCbGaD
Doxylamine—Orphenadrine—SCN10A—breast cancer	6.42e-05	0.0277	CrCbGaD
Doxylamine—Clemastine—CYP2D6—breast cancer	6.41e-05	0.0276	CrCbGaD
Doxylamine—Levomethadyl Acetate—CYP19A1—breast cancer	6.27e-05	0.027	CrCbGaD
Doxylamine—Mepyramine—CYP2D6—breast cancer	5.72e-05	0.0246	CrCbGaD
Doxylamine—Tamoxifen—ESR2—breast cancer	5.54e-05	0.0239	CrCbGaD
Doxylamine—Clemastine—CYP3A4—breast cancer	5.5e-05	0.0237	CrCbGaD
Doxylamine—Tripelennamine—CYP2D6—breast cancer	5.29e-05	0.0228	CrCbGaD
Doxylamine—Tamoxifen—CYP1B1—breast cancer	5.05e-05	0.0218	CrCbGaD
Doxylamine—Cyclobenzaprine—CYP2D6—breast cancer	4.39e-05	0.0189	CrCbGaD
Doxylamine—Toremifene—CYP3A4—breast cancer	4.36e-05	0.0188	CrCbGaD
Doxylamine—Vomiting—Thiotepa—breast cancer	3.9e-05	0.000447	CcSEcCtD
Doxylamine—Leukopenia—Capecitabine—breast cancer	3.88e-05	0.000445	CcSEcCtD
Doxylamine—Convulsion—Docetaxel—breast cancer	3.88e-05	0.000445	CcSEcCtD
Doxylamine—Drowsiness—Epirubicin—breast cancer	3.87e-05	0.000443	CcSEcCtD
Doxylamine—Rash—Thiotepa—breast cancer	3.86e-05	0.000443	CcSEcCtD
Doxylamine—Dermatitis—Thiotepa—breast cancer	3.86e-05	0.000442	CcSEcCtD
Doxylamine—Agranulocytosis—Methotrexate—breast cancer	3.86e-05	0.000442	CcSEcCtD
Doxylamine—Dyspnoea—Paclitaxel—breast cancer	3.85e-05	0.000441	CcSEcCtD
Doxylamine—Somnolence—Paclitaxel—breast cancer	3.84e-05	0.00044	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Epirubicin—breast cancer	3.83e-05	0.00044	CcSEcCtD
Doxylamine—Palpitations—Capecitabine—breast cancer	3.83e-05	0.00044	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—breast cancer	3.81e-05	0.000437	CcSEcCtD
Doxylamine—Nausea—Vinorelbine—breast cancer	3.81e-05	0.000437	CcSEcCtD
Doxylamine—Asthenia—Irinotecan—breast cancer	3.8e-05	0.000435	CcSEcCtD
Doxylamine—Asthenia—Mitoxantrone—breast cancer	3.8e-05	0.000435	CcSEcCtD
Doxylamine—Cyclobenzaprine—CYP3A4—breast cancer	3.77e-05	0.0163	CrCbGaD
Doxylamine—Decreased appetite—Paclitaxel—breast cancer	3.75e-05	0.00043	CcSEcCtD
Doxylamine—Hypersensitivity—Fluorouracil—breast cancer	3.73e-05	0.000428	CcSEcCtD
Doxylamine—Dry mouth—Docetaxel—breast cancer	3.73e-05	0.000428	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Paclitaxel—breast cancer	3.73e-05	0.000427	CcSEcCtD
Doxylamine—Fatigue—Paclitaxel—breast cancer	3.72e-05	0.000427	CcSEcCtD
Doxylamine—Hepatitis—Methotrexate—breast cancer	3.71e-05	0.000425	CcSEcCtD
Doxylamine—Tamoxifen—CYP19A1—breast cancer	3.71e-05	0.016	CrCbGaD
Doxylamine—Sweating—Epirubicin—breast cancer	3.71e-05	0.000425	CcSEcCtD
Doxylamine—Asthenia—Gemcitabine—breast cancer	3.7e-05	0.000424	CcSEcCtD
Doxylamine—Constipation—Paclitaxel—breast cancer	3.69e-05	0.000423	CcSEcCtD
Doxylamine—Confusional state—Docetaxel—breast cancer	3.69e-05	0.000423	CcSEcCtD
Doxylamine—Anxiety—Capecitabine—breast cancer	3.68e-05	0.000422	CcSEcCtD
Doxylamine—Methadone—CYP19A1—breast cancer	3.68e-05	0.0159	CrCbGaD
Doxylamine—Urinary tract disorder—Methotrexate—breast cancer	3.66e-05	0.00042	CcSEcCtD
Doxylamine—Anaphylactic shock—Docetaxel—breast cancer	3.66e-05	0.000419	CcSEcCtD
Doxylamine—Discomfort—Capecitabine—breast cancer	3.65e-05	0.000418	CcSEcCtD
Doxylamine—Pruritus—Gemcitabine—breast cancer	3.65e-05	0.000418	CcSEcCtD
Doxylamine—Nausea—Thiotepa—breast cancer	3.64e-05	0.000417	CcSEcCtD
Doxylamine—Urethral disorder—Methotrexate—breast cancer	3.64e-05	0.000417	CcSEcCtD
Doxylamine—Toremifene—ABCB1—breast cancer	3.63e-05	0.0157	CrCbGaD
Doxylamine—Diarrhoea—Mitoxantrone—breast cancer	3.62e-05	0.000415	CcSEcCtD
Doxylamine—Diarrhoea—Irinotecan—breast cancer	3.62e-05	0.000415	CcSEcCtD
Doxylamine—Carbinoxamine—CYP2D6—breast cancer	3.61e-05	0.0156	CrCbGaD
Doxylamine—Disopyramide—CYP3A4—breast cancer	3.61e-05	0.0156	CrCbGaD
Doxylamine—Dry mouth—Capecitabine—breast cancer	3.61e-05	0.000414	CcSEcCtD
Doxylamine—Agranulocytosis—Epirubicin—breast cancer	3.61e-05	0.000414	CcSEcCtD
Doxylamine—Nervous system disorder—Docetaxel—breast cancer	3.59e-05	0.000411	CcSEcCtD
Doxylamine—Pruritus—Fluorouracil—breast cancer	3.59e-05	0.000411	CcSEcCtD
Doxylamine—Thrombocytopenia—Docetaxel—breast cancer	3.58e-05	0.000411	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—breast cancer	3.58e-05	0.00041	CcSEcCtD
Doxylamine—Confusional state—Capecitabine—breast cancer	3.57e-05	0.000409	CcSEcCtD
Doxylamine—Tachycardia—Docetaxel—breast cancer	3.57e-05	0.000409	CcSEcCtD
Doxylamine—Feeling abnormal—Paclitaxel—breast cancer	3.56e-05	0.000408	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	3.55e-05	0.000407	CcSEcCtD
Doxylamine—Bradycardia—Epirubicin—breast cancer	3.53e-05	0.000405	CcSEcCtD
Doxylamine—Diarrhoea—Gemcitabine—breast cancer	3.53e-05	0.000404	CcSEcCtD
Doxylamine—Erythema multiforme—Methotrexate—breast cancer	3.51e-05	0.000402	CcSEcCtD
Doxylamine—Dizziness—Irinotecan—breast cancer	3.5e-05	0.000401	CcSEcCtD
Doxylamine—Anorexia—Docetaxel—breast cancer	3.49e-05	0.0004	CcSEcCtD
Doxylamine—Tamoxifen—ABCG2—breast cancer	3.48e-05	0.015	CrCbGaD
Doxylamine—Nervous system disorder—Capecitabine—breast cancer	3.47e-05	0.000398	CcSEcCtD
Doxylamine—Hepatitis—Epirubicin—breast cancer	3.47e-05	0.000398	CcSEcCtD
Doxylamine—Eye disorder—Methotrexate—breast cancer	3.47e-05	0.000398	CcSEcCtD
Doxylamine—Diarrhoea—Fluorouracil—breast cancer	3.47e-05	0.000398	CcSEcCtD
Doxylamine—Thrombocytopenia—Capecitabine—breast cancer	3.47e-05	0.000398	CcSEcCtD
Doxylamine—Tachycardia—Capecitabine—breast cancer	3.46e-05	0.000396	CcSEcCtD
Doxylamine—Cardiac disorder—Methotrexate—breast cancer	3.44e-05	0.000395	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—breast cancer	3.43e-05	0.000393	CcSEcCtD
Doxylamine—Urinary tract disorder—Epirubicin—breast cancer	3.43e-05	0.000393	CcSEcCtD
Doxylamine—Urticaria—Paclitaxel—breast cancer	3.43e-05	0.000393	CcSEcCtD
Doxylamine—Hyperhidrosis—Capecitabine—breast cancer	3.42e-05	0.000392	CcSEcCtD
Doxylamine—Hypotension—Docetaxel—breast cancer	3.42e-05	0.000392	CcSEcCtD
Doxylamine—Tamoxifen—ESR1—breast cancer	3.41e-05	0.0147	CrCbGaD
Doxylamine—Urethral disorder—Epirubicin—breast cancer	3.4e-05	0.00039	CcSEcCtD
Doxylamine—Anorexia—Capecitabine—breast cancer	3.38e-05	0.000387	CcSEcCtD
Doxylamine—Vomiting—Mitoxantrone—breast cancer	3.36e-05	0.000386	CcSEcCtD
Doxylamine—Vomiting—Irinotecan—breast cancer	3.36e-05	0.000386	CcSEcCtD
Doxylamine—Immune system disorder—Methotrexate—breast cancer	3.35e-05	0.000384	CcSEcCtD
Doxylamine—Dizziness—Fluorouracil—breast cancer	3.35e-05	0.000384	CcSEcCtD
Doxylamine—Mediastinal disorder—Methotrexate—breast cancer	3.34e-05	0.000383	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—breast cancer	3.34e-05	0.000383	CcSEcCtD
Doxylamine—Rash—Mitoxantrone—breast cancer	3.34e-05	0.000382	CcSEcCtD
Doxylamine—Rash—Irinotecan—breast cancer	3.34e-05	0.000382	CcSEcCtD
Doxylamine—Dermatitis—Mitoxantrone—breast cancer	3.33e-05	0.000382	CcSEcCtD
Doxylamine—Dermatitis—Irinotecan—breast cancer	3.33e-05	0.000382	CcSEcCtD
Doxylamine—Hypotension—Capecitabine—breast cancer	3.31e-05	0.000379	CcSEcCtD
Doxylamine—Insomnia—Docetaxel—breast cancer	3.31e-05	0.000379	CcSEcCtD
Doxylamine—Erythema multiforme—Epirubicin—breast cancer	3.28e-05	0.000376	CcSEcCtD
Doxylamine—Vomiting—Gemcitabine—breast cancer	3.28e-05	0.000376	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—breast cancer	3.27e-05	0.000375	CcSEcCtD
Doxylamine—Dyspnoea—Docetaxel—breast cancer	3.26e-05	0.000374	CcSEcCtD
Doxylamine—Somnolence—Docetaxel—breast cancer	3.25e-05	0.000373	CcSEcCtD
Doxylamine—Rash—Gemcitabine—breast cancer	3.25e-05	0.000373	CcSEcCtD
Doxylamine—Dermatitis—Gemcitabine—breast cancer	3.25e-05	0.000372	CcSEcCtD
Doxylamine—Eye disorder—Epirubicin—breast cancer	3.24e-05	0.000372	CcSEcCtD
Doxylamine—Erythema—Methotrexate—breast cancer	3.23e-05	0.00037	CcSEcCtD
Doxylamine—Flushing—Epirubicin—breast cancer	3.22e-05	0.000369	CcSEcCtD
Doxylamine—Cardiac disorder—Epirubicin—breast cancer	3.22e-05	0.000369	CcSEcCtD
Doxylamine—Vomiting—Fluorouracil—breast cancer	3.22e-05	0.000369	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—breast cancer	3.21e-05	0.000368	CcSEcCtD
Doxylamine—Insomnia—Capecitabine—breast cancer	3.2e-05	0.000367	CcSEcCtD
Doxylamine—Rash—Fluorouracil—breast cancer	3.19e-05	0.000366	CcSEcCtD
Doxylamine—Dermatitis—Fluorouracil—breast cancer	3.19e-05	0.000366	CcSEcCtD
Doxylamine—Decreased appetite—Docetaxel—breast cancer	3.18e-05	0.000365	CcSEcCtD
Doxylamine—Hypersensitivity—Paclitaxel—breast cancer	3.18e-05	0.000365	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—breast cancer	3.17e-05	0.000364	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Docetaxel—breast cancer	3.16e-05	0.000362	CcSEcCtD
Doxylamine—Dyspnoea—Capecitabine—breast cancer	3.16e-05	0.000362	CcSEcCtD
Doxylamine—Fatigue—Docetaxel—breast cancer	3.15e-05	0.000362	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—breast cancer	3.15e-05	0.000361	CcSEcCtD
Doxylamine—Nausea—Irinotecan—breast cancer	3.14e-05	0.00036	CcSEcCtD
Doxylamine—Nausea—Mitoxantrone—breast cancer	3.14e-05	0.00036	CcSEcCtD
Doxylamine—Immune system disorder—Epirubicin—breast cancer	3.14e-05	0.00036	CcSEcCtD
Doxylamine—Brompheniramine—CYP2D6—breast cancer	3.13e-05	0.0135	CrCbGaD
Doxylamine—Mediastinal disorder—Epirubicin—breast cancer	3.13e-05	0.000359	CcSEcCtD
Doxylamine—Constipation—Docetaxel—breast cancer	3.13e-05	0.000359	CcSEcCtD
Doxylamine—Carbinoxamine—CYP3A4—breast cancer	3.1e-05	0.0134	CrCbGaD
Doxylamine—Asthenia—Paclitaxel—breast cancer	3.1e-05	0.000355	CcSEcCtD
Doxylamine—Decreased appetite—Capecitabine—breast cancer	3.08e-05	0.000353	CcSEcCtD
Doxylamine—Chlorphenamine—CYP2D6—breast cancer	3.07e-05	0.0133	CrCbGaD
Doxylamine—Diphenhydramine—PTGS1—breast cancer	3.06e-05	0.0132	CrCbGaD
Doxylamine—Nausea—Gemcitabine—breast cancer	3.06e-05	0.000351	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Capecitabine—breast cancer	3.06e-05	0.000351	CcSEcCtD
Doxylamine—Fatigue—Capecitabine—breast cancer	3.05e-05	0.00035	CcSEcCtD
Doxylamine—Pruritus—Paclitaxel—breast cancer	3.05e-05	0.00035	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—breast cancer	3.04e-05	0.000348	CcSEcCtD
Doxylamine—Constipation—Capecitabine—breast cancer	3.03e-05	0.000347	CcSEcCtD
Doxylamine—Erythema—Epirubicin—breast cancer	3.02e-05	0.000347	CcSEcCtD
Doxylamine—Feeling abnormal—Docetaxel—breast cancer	3.01e-05	0.000346	CcSEcCtD
Doxylamine—Nausea—Fluorouracil—breast cancer	3.01e-05	0.000345	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—breast cancer	3e-05	0.000344	CcSEcCtD
Doxylamine—Ill-defined disorder—Methotrexate—breast cancer	3e-05	0.000344	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—breast cancer	2.98e-05	0.000342	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—breast cancer	2.98e-05	0.000342	CcSEcCtD
Doxylamine—Dextropropoxyphene—CYP2D6—breast cancer	2.97e-05	0.0128	CrCbGaD
Doxylamine—Diarrhoea—Paclitaxel—breast cancer	2.95e-05	0.000339	CcSEcCtD
Doxylamine—Levomethadyl Acetate—CYP3A4—breast cancer	2.95e-05	0.0127	CrCbGaD
Doxylamine—Feeling abnormal—Capecitabine—breast cancer	2.92e-05	0.000335	CcSEcCtD
Doxylamine—Malaise—Methotrexate—breast cancer	2.91e-05	0.000334	CcSEcCtD
Doxylamine—Muscle spasms—Epirubicin—breast cancer	2.91e-05	0.000333	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—breast cancer	2.9e-05	0.000333	CcSEcCtD
Doxylamine—Vertigo—Methotrexate—breast cancer	2.9e-05	0.000333	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—breast cancer	2.9e-05	0.000332	CcSEcCtD
Doxylamine—Leukopenia—Methotrexate—breast cancer	2.89e-05	0.000331	CcSEcCtD
Doxylamine—Dizziness—Paclitaxel—breast cancer	2.85e-05	0.000327	CcSEcCtD
Doxylamine—Urticaria—Capecitabine—breast cancer	2.81e-05	0.000323	CcSEcCtD
Doxylamine—Ill-defined disorder—Epirubicin—breast cancer	2.8e-05	0.000322	CcSEcCtD
Doxylamine—Convulsion—Methotrexate—breast cancer	2.8e-05	0.000321	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—breast cancer	2.8e-05	0.000321	CcSEcCtD
Doxylamine—Agitation—Epirubicin—breast cancer	2.78e-05	0.000318	CcSEcCtD
Doxylamine—Vomiting—Paclitaxel—breast cancer	2.74e-05	0.000315	CcSEcCtD
Doxylamine—Tamoxifen—CYP1A1—breast cancer	2.73e-05	0.0118	CrCbGaD
Doxylamine—Malaise—Epirubicin—breast cancer	2.73e-05	0.000313	CcSEcCtD
Doxylamine—Rash—Paclitaxel—breast cancer	2.72e-05	0.000312	CcSEcCtD
Doxylamine—Dermatitis—Paclitaxel—breast cancer	2.72e-05	0.000312	CcSEcCtD
Doxylamine—Discomfort—Methotrexate—breast cancer	2.72e-05	0.000312	CcSEcCtD
Doxylamine—Vertigo—Epirubicin—breast cancer	2.72e-05	0.000311	CcSEcCtD
Doxylamine—Leukopenia—Epirubicin—breast cancer	2.71e-05	0.00031	CcSEcCtD
Doxylamine—Hypersensitivity—Docetaxel—breast cancer	2.69e-05	0.000309	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—breast cancer	2.69e-05	0.000308	CcSEcCtD
Doxylamine—Brompheniramine—CYP3A4—breast cancer	2.69e-05	0.0116	CrCbGaD
Doxylamine—Palpitations—Epirubicin—breast cancer	2.67e-05	0.000306	CcSEcCtD
Doxylamine—Confusional state—Methotrexate—breast cancer	2.66e-05	0.000305	CcSEcCtD
Doxylamine—Chlorphenamine—CYP3A4—breast cancer	2.64e-05	0.0114	CrCbGaD
Doxylamine—Anaphylactic shock—Methotrexate—breast cancer	2.64e-05	0.000302	CcSEcCtD
Doxylamine—Asthenia—Docetaxel—breast cancer	2.62e-05	0.000301	CcSEcCtD
Doxylamine—Convulsion—Epirubicin—breast cancer	2.62e-05	0.0003	CcSEcCtD
Doxylamine—Hypersensitivity—Capecitabine—breast cancer	2.61e-05	0.000299	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—breast cancer	2.59e-05	0.000298	CcSEcCtD
Doxylamine—Pruritus—Docetaxel—breast cancer	2.59e-05	0.000297	CcSEcCtD
Doxylamine—Nervous system disorder—Methotrexate—breast cancer	2.59e-05	0.000296	CcSEcCtD
Doxylamine—Atomoxetine—CYP2D6—breast cancer	2.58e-05	0.0111	CrCbGaD
Doxylamine—Thrombocytopenia—Methotrexate—breast cancer	2.58e-05	0.000296	CcSEcCtD
Doxylamine—Agitation—Doxorubicin—breast cancer	2.57e-05	0.000295	CcSEcCtD
Doxylamine—Anxiety—Epirubicin—breast cancer	2.56e-05	0.000294	CcSEcCtD
Doxylamine—Nausea—Paclitaxel—breast cancer	2.56e-05	0.000294	CcSEcCtD
Doxylamine—Hyperhidrosis—Methotrexate—breast cancer	2.55e-05	0.000292	CcSEcCtD
Doxylamine—Dextropropoxyphene—CYP3A4—breast cancer	2.55e-05	0.011	CrCbGaD
Doxylamine—Discomfort—Epirubicin—breast cancer	2.54e-05	0.000292	CcSEcCtD
Doxylamine—Asthenia—Capecitabine—breast cancer	2.54e-05	0.000291	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—breast cancer	2.52e-05	0.000289	CcSEcCtD
Doxylamine—Dry mouth—Epirubicin—breast cancer	2.52e-05	0.000289	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—breast cancer	2.51e-05	0.000288	CcSEcCtD
Doxylamine—Anorexia—Methotrexate—breast cancer	2.51e-05	0.000288	CcSEcCtD
Doxylamine—Pruritus—Capecitabine—breast cancer	2.51e-05	0.000287	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—breast cancer	2.5e-05	0.000287	CcSEcCtD
Doxylamine—Diarrhoea—Docetaxel—breast cancer	2.5e-05	0.000287	CcSEcCtD
Doxylamine—Confusional state—Epirubicin—breast cancer	2.49e-05	0.000285	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—breast cancer	2.47e-05	0.000283	CcSEcCtD
Doxylamine—Anaphylactic shock—Epirubicin—breast cancer	2.47e-05	0.000283	CcSEcCtD
Doxylamine—Hypotension—Methotrexate—breast cancer	2.46e-05	0.000282	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—breast cancer	2.42e-05	0.000278	CcSEcCtD
Doxylamine—Diarrhoea—Capecitabine—breast cancer	2.42e-05	0.000278	CcSEcCtD
Doxylamine—Nervous system disorder—Epirubicin—breast cancer	2.42e-05	0.000277	CcSEcCtD
Doxylamine—Dizziness—Docetaxel—breast cancer	2.42e-05	0.000277	CcSEcCtD
Doxylamine—Thrombocytopenia—Epirubicin—breast cancer	2.42e-05	0.000277	CcSEcCtD
Doxylamine—Tachycardia—Epirubicin—breast cancer	2.41e-05	0.000276	CcSEcCtD
Doxylamine—Hyperhidrosis—Epirubicin—breast cancer	2.38e-05	0.000273	CcSEcCtD
Doxylamine—Insomnia—Methotrexate—breast cancer	2.38e-05	0.000273	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—breast cancer	2.37e-05	0.000272	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—breast cancer	2.35e-05	0.00027	CcSEcCtD
Doxylamine—Anorexia—Epirubicin—breast cancer	2.35e-05	0.00027	CcSEcCtD
Doxylamine—Dyspnoea—Methotrexate—breast cancer	2.35e-05	0.000269	CcSEcCtD
Doxylamine—Somnolence—Methotrexate—breast cancer	2.34e-05	0.000269	CcSEcCtD
Doxylamine—Dizziness—Capecitabine—breast cancer	2.34e-05	0.000268	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—breast cancer	2.33e-05	0.000267	CcSEcCtD
Doxylamine—Vomiting—Docetaxel—breast cancer	2.33e-05	0.000267	CcSEcCtD
Doxylamine—Rash—Docetaxel—breast cancer	2.31e-05	0.000264	CcSEcCtD
Doxylamine—Hypotension—Epirubicin—breast cancer	2.31e-05	0.000264	CcSEcCtD
Doxylamine—Dermatitis—Docetaxel—breast cancer	2.3e-05	0.000264	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—breast cancer	2.3e-05	0.000264	CcSEcCtD
Doxylamine—Decreased appetite—Methotrexate—breast cancer	2.29e-05	0.000263	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—breast cancer	2.28e-05	0.000262	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Methotrexate—breast cancer	2.28e-05	0.000261	CcSEcCtD
Doxylamine—Fatigue—Methotrexate—breast cancer	2.27e-05	0.000261	CcSEcCtD
Doxylamine—Vomiting—Capecitabine—breast cancer	2.25e-05	0.000258	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—breast cancer	2.24e-05	0.000257	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—breast cancer	2.23e-05	0.000256	CcSEcCtD
Doxylamine—Benzphetamine—CYP3A4—breast cancer	2.23e-05	0.00963	CrCbGaD
Doxylamine—Rash—Capecitabine—breast cancer	2.23e-05	0.000256	CcSEcCtD
Doxylamine—Insomnia—Epirubicin—breast cancer	2.23e-05	0.000256	CcSEcCtD
Doxylamine—Dermatitis—Capecitabine—breast cancer	2.23e-05	0.000256	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—breast cancer	2.23e-05	0.000255	CcSEcCtD
Doxylamine—Atomoxetine—CYP3A4—breast cancer	2.22e-05	0.00955	CrCbGaD
Doxylamine—Hyperhidrosis—Doxorubicin—breast cancer	2.21e-05	0.000253	CcSEcCtD
Doxylamine—Dyspnoea—Epirubicin—breast cancer	2.2e-05	0.000252	CcSEcCtD
Doxylamine—Somnolence—Epirubicin—breast cancer	2.19e-05	0.000251	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—breast cancer	2.18e-05	0.000249	CcSEcCtD
Doxylamine—Nausea—Docetaxel—breast cancer	2.17e-05	0.000249	CcSEcCtD
Doxylamine—Feeling abnormal—Methotrexate—breast cancer	2.17e-05	0.000249	CcSEcCtD
Doxylamine—Decreased appetite—Epirubicin—breast cancer	2.14e-05	0.000246	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—breast cancer	2.13e-05	0.000245	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Epirubicin—breast cancer	2.13e-05	0.000244	CcSEcCtD
Doxylamine—Fatigue—Epirubicin—breast cancer	2.13e-05	0.000244	CcSEcCtD
Doxylamine—Constipation—Epirubicin—breast cancer	2.11e-05	0.000242	CcSEcCtD
Doxylamine—Nausea—Capecitabine—breast cancer	2.1e-05	0.000241	CcSEcCtD
Doxylamine—Urticaria—Methotrexate—breast cancer	2.09e-05	0.00024	CcSEcCtD
Doxylamine—Diphenhydramine—CYP2D6—breast cancer	2.09e-05	0.00899	CrCbGaD
Doxylamine—Insomnia—Doxorubicin—breast cancer	2.06e-05	0.000237	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—breast cancer	2.03e-05	0.000233	CcSEcCtD
Doxylamine—Feeling abnormal—Epirubicin—breast cancer	2.03e-05	0.000233	CcSEcCtD
Doxylamine—Tamoxifen—CYP2D6—breast cancer	2.03e-05	0.00876	CrCbGaD
Doxylamine—Somnolence—Doxorubicin—breast cancer	2.03e-05	0.000233	CcSEcCtD
Doxylamine—Doxepin—CYP2D6—breast cancer	2.02e-05	0.00873	CrCbGaD
Doxylamine—Methadone—CYP2D6—breast cancer	2.01e-05	0.00868	CrCbGaD
Doxylamine—Decreased appetite—Doxorubicin—breast cancer	1.98e-05	0.000228	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.97e-05	0.000226	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—breast cancer	1.97e-05	0.000226	CcSEcCtD
Doxylamine—Urticaria—Epirubicin—breast cancer	1.96e-05	0.000225	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—breast cancer	1.95e-05	0.000224	CcSEcCtD
Doxylamine—Hypersensitivity—Methotrexate—breast cancer	1.94e-05	0.000223	CcSEcCtD
Doxylamine—Asthenia—Methotrexate—breast cancer	1.89e-05	0.000217	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—breast cancer	1.88e-05	0.000216	CcSEcCtD
Doxylamine—Pruritus—Methotrexate—breast cancer	1.86e-05	0.000214	CcSEcCtD
Doxylamine—Hypersensitivity—Epirubicin—breast cancer	1.82e-05	0.000208	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—breast cancer	1.81e-05	0.000208	CcSEcCtD
Doxylamine—Diarrhoea—Methotrexate—breast cancer	1.8e-05	0.000207	CcSEcCtD
Doxylamine—Asthenia—Epirubicin—breast cancer	1.77e-05	0.000203	CcSEcCtD
Doxylamine—Pruritus—Epirubicin—breast cancer	1.75e-05	0.0002	CcSEcCtD
Doxylamine—Dizziness—Methotrexate—breast cancer	1.74e-05	0.0002	CcSEcCtD
Doxylamine—Tamoxifen—CYP3A4—breast cancer	1.74e-05	0.00751	CrCbGaD
Doxylamine—Doxepin—CYP3A4—breast cancer	1.74e-05	0.00749	CrCbGaD
Doxylamine—Methadone—CYP3A4—breast cancer	1.73e-05	0.00745	CrCbGaD
Doxylamine—Orphenadrine—CYP3A4—breast cancer	1.69e-05	0.0073	CrCbGaD
Doxylamine—Diarrhoea—Epirubicin—breast cancer	1.69e-05	0.000194	CcSEcCtD
Doxylamine—Hypersensitivity—Doxorubicin—breast cancer	1.68e-05	0.000193	CcSEcCtD
Doxylamine—Vomiting—Methotrexate—breast cancer	1.68e-05	0.000192	CcSEcCtD
Doxylamine—Rash—Methotrexate—breast cancer	1.66e-05	0.000191	CcSEcCtD
Doxylamine—Dermatitis—Methotrexate—breast cancer	1.66e-05	0.00019	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—breast cancer	1.64e-05	0.000188	CcSEcCtD
Doxylamine—Dizziness—Epirubicin—breast cancer	1.63e-05	0.000187	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—breast cancer	1.61e-05	0.000185	CcSEcCtD
Doxylamine—Imipramine—CYP2D6—breast cancer	1.58e-05	0.00679	CrCbGaD
Doxylamine—Vomiting—Epirubicin—breast cancer	1.57e-05	0.00018	CcSEcCtD
Doxylamine—Nausea—Methotrexate—breast cancer	1.57e-05	0.00018	CcSEcCtD
Doxylamine—Amitriptyline—CYP2D6—breast cancer	1.57e-05	0.00675	CrCbGaD
Doxylamine—Diarrhoea—Doxorubicin—breast cancer	1.56e-05	0.000179	CcSEcCtD
Doxylamine—Rash—Epirubicin—breast cancer	1.56e-05	0.000178	CcSEcCtD
Doxylamine—Dermatitis—Epirubicin—breast cancer	1.55e-05	0.000178	CcSEcCtD
Doxylamine—Promazine—CYP3A4—breast cancer	1.54e-05	0.00665	CrCbGaD
Doxylamine—Dizziness—Doxorubicin—breast cancer	1.51e-05	0.000173	CcSEcCtD
Doxylamine—Nausea—Epirubicin—breast cancer	1.47e-05	0.000168	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—breast cancer	1.45e-05	0.000166	CcSEcCtD
Doxylamine—Tamoxifen—ABCB1—breast cancer	1.45e-05	0.00625	CrCbGaD
Doxylamine—Doxepin—ABCB1—breast cancer	1.45e-05	0.00623	CrCbGaD
Doxylamine—Rash—Doxorubicin—breast cancer	1.44e-05	0.000165	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—breast cancer	1.44e-05	0.000165	CcSEcCtD
Doxylamine—Methadone—ABCB1—breast cancer	1.44e-05	0.0062	CrCbGaD
Doxylamine—Nausea—Doxorubicin—breast cancer	1.36e-05	0.000155	CcSEcCtD
Doxylamine—Imipramine—CYP3A4—breast cancer	1.35e-05	0.00583	CrCbGaD
Doxylamine—Amitriptyline—CYP3A4—breast cancer	1.34e-05	0.00579	CrCbGaD
Doxylamine—Amitriptyline—ALB—breast cancer	1.17e-05	0.00505	CrCbGaD
Doxylamine—Imipramine—ABCB1—breast cancer	1.12e-05	0.00485	CrCbGaD
Doxylamine—Amitriptyline—ABCB1—breast cancer	1.12e-05	0.00482	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—JAG2—breast cancer	1.11e-06	0.000708	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JAG2—breast cancer	1.11e-06	0.000705	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—WNT1—breast cancer	1.1e-06	0.000698	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	1.09e-06	0.000696	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—WNT1—breast cancer	1.09e-06	0.000695	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PLA2G4A—breast cancer	1.09e-06	0.000694	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CSF2—breast cancer	1.08e-06	0.000688	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CSF2—breast cancer	1.08e-06	0.000686	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOTCH4—breast cancer	1.04e-06	0.000661	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOTCH4—breast cancer	1.03e-06	0.000659	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GZMB—breast cancer	1.03e-06	0.000657	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GZMB—breast cancer	1.03e-06	0.000655	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGTR2—breast cancer	1e-06	0.000638	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL2—breast cancer	1e-06	0.000638	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL2—breast cancer	9.98e-07	0.000636	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGTR2—breast cancer	9.98e-07	0.000636	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PTHLH—breast cancer	9.9e-07	0.000631	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—BMP2—breast cancer	9.9e-07	0.000631	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—BMP2—breast cancer	9.87e-07	0.000629	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PTHLH—breast cancer	9.87e-07	0.000629	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDNRB—breast cancer	9.59e-07	0.000611	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDNRB—breast cancer	9.56e-07	0.000609	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PGR—breast cancer	9.5e-07	0.000605	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PGR—breast cancer	9.47e-07	0.000603	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—THBS1—breast cancer	9.45e-07	0.000602	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—THBS1—breast cancer	9.42e-07	0.0006	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FLT1—breast cancer	9.02e-07	0.000574	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FLT1—breast cancer	8.99e-07	0.000573	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF3—breast cancer	8.98e-07	0.000572	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SQSTM1—breast cancer	8.98e-07	0.000572	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF3—breast cancer	8.95e-07	0.00057	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SQSTM1—breast cancer	8.95e-07	0.00057	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	8.93e-07	0.000569	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PIK3CG—breast cancer	8.91e-07	0.000567	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—JAG1—breast cancer	8.86e-07	0.000565	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JAG1—breast cancer	8.84e-07	0.000563	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOTCH3—breast cancer	8.83e-07	0.000562	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PARP1—breast cancer	8.83e-07	0.000562	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PARP1—breast cancer	8.8e-07	0.00056	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOTCH3—breast cancer	8.8e-07	0.00056	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CALCA—breast cancer	8.72e-07	0.000555	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CALCA—breast cancer	8.69e-07	0.000554	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RPS6—breast cancer	8.62e-07	0.000549	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RPS6—breast cancer	8.59e-07	0.000547	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF4—breast cancer	8.55e-07	0.000545	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF4—breast cancer	8.52e-07	0.000543	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCR4—breast cancer	8.52e-07	0.000542	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL12—breast cancer	8.52e-07	0.000542	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL12—breast cancer	8.49e-07	0.000541	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCR4—breast cancer	8.49e-07	0.000541	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PAK1—breast cancer	8.36e-07	0.000532	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PAK1—breast cancer	8.33e-07	0.000531	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TCF7L2—breast cancer	8.21e-07	0.000523	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TCF7L2—breast cancer	8.19e-07	0.000521	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT2—breast cancer	8.17e-07	0.000521	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT2—breast cancer	8.15e-07	0.000519	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	8.11e-07	0.000517	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PIK3CG—breast cancer	8.09e-07	0.000515	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOTCH2—breast cancer	7.92e-07	0.000504	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	7.92e-07	0.000504	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HSP90AA1—breast cancer	7.89e-07	0.000503	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOTCH2—breast cancer	7.89e-07	0.000503	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	7.85e-07	0.0005	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PIK3CD—breast cancer	7.83e-07	0.000499	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGTR1—breast cancer	7.7e-07	0.000491	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRL—breast cancer	7.7e-07	0.000491	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRL—breast cancer	7.68e-07	0.000489	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGTR1—breast cancer	7.68e-07	0.000489	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADAM10—breast cancer	7.59e-07	0.000483	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—STK11—breast cancer	7.59e-07	0.000483	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—STK11—breast cancer	7.57e-07	0.000482	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADAM10—breast cancer	7.57e-07	0.000482	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLG—breast cancer	7.51e-07	0.000478	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLG—breast cancer	7.48e-07	0.000477	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT2—breast cancer	7.42e-07	0.000473	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT2—breast cancer	7.4e-07	0.000471	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF10—breast cancer	7.38e-07	0.00047	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF10—breast cancer	7.36e-07	0.000469	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	7.13e-07	0.000454	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PDGFA—breast cancer	7.13e-07	0.000454	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PIK3CD—breast cancer	7.11e-07	0.000453	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PDGFA—breast cancer	7.1e-07	0.000452	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TGFBR2—breast cancer	7.02e-07	0.000447	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TGFBR2—breast cancer	7e-07	0.000446	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ITPR1—breast cancer	6.91e-07	0.00044	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ITPR1—breast cancer	6.89e-07	0.000439	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ERBB4—breast cancer	6.87e-07	0.000437	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—STAT5A—breast cancer	6.87e-07	0.000437	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP3—breast cancer	6.87e-07	0.000437	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	6.85e-07	0.000436	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP3—breast cancer	6.84e-07	0.000436	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ERBB4—breast cancer	6.84e-07	0.000436	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—STAT5A—breast cancer	6.84e-07	0.000436	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PIK3CB—breast cancer	6.82e-07	0.000435	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SMAD4—breast cancer	6.65e-07	0.000423	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SMAD4—breast cancer	6.63e-07	0.000422	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1R—breast cancer	6.61e-07	0.000421	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1R—breast cancer	6.59e-07	0.00042	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	6.58e-07	0.000419	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	6.56e-07	0.000418	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HES1—breast cancer	6.49e-07	0.000413	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HES1—breast cancer	6.47e-07	0.000412	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NCOR1—breast cancer	6.45e-07	0.000411	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	6.45e-07	0.000411	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	6.43e-07	0.00041	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NCOR1—breast cancer	6.43e-07	0.00041	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CSF2—breast cancer	6.38e-07	0.000406	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF1—breast cancer	6.38e-07	0.000406	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—RAF1—breast cancer	6.37e-07	0.000406	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CSF2—breast cancer	6.36e-07	0.000405	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF1—breast cancer	6.36e-07	0.000405	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—RAF1—breast cancer	6.35e-07	0.000404	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NRG1—breast cancer	6.34e-07	0.000404	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NRG1—breast cancer	6.32e-07	0.000402	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—H2AFX—breast cancer	6.29e-07	0.000401	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—IL2—breast cancer	6.29e-07	0.0004	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—H2AFX—breast cancer	6.27e-07	0.000399	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—IL2—breast cancer	6.27e-07	0.000399	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—E2F1—breast cancer	6.25e-07	0.000398	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—E2F1—breast cancer	6.23e-07	0.000397	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	6.22e-07	0.000396	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	6.2e-07	0.000395	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SPP1—breast cancer	6e-07	0.000382	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SPP1—breast cancer	5.98e-07	0.000381	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CXCL8—breast cancer	5.97e-07	0.00038	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CXCL8—breast cancer	5.96e-07	0.000379	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ERBB3—breast cancer	5.94e-07	0.000378	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGFR2—breast cancer	5.93e-07	0.000377	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ERBB3—breast cancer	5.92e-07	0.000377	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGFR2—breast cancer	5.91e-07	0.000376	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL2—breast cancer	5.71e-07	0.000364	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL2—breast cancer	5.69e-07	0.000362	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TERT—breast cancer	5.69e-07	0.000362	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TERT—breast cancer	5.67e-07	0.000361	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGFR1—breast cancer	5.52e-07	0.000352	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGFR1—breast cancer	5.51e-07	0.000351	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HIF1A—breast cancer	5.44e-07	0.000346	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HIF1A—breast cancer	5.42e-07	0.000345	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LEP—breast cancer	5.31e-07	0.000338	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LEP—breast cancer	5.29e-07	0.000337	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CAV1—breast cancer	5.26e-07	0.000335	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CAV1—breast cancer	5.24e-07	0.000334	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KDR—breast cancer	5.2e-07	0.000331	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KDR—breast cancer	5.19e-07	0.00033	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ESR1—breast cancer	5.07e-07	0.000323	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ESR1—breast cancer	5.05e-07	0.000322	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FN1—breast cancer	5.01e-07	0.000319	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FN1—breast cancer	4.99e-07	0.000318	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NFKBIA—breast cancer	4.95e-07	0.000315	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NFKBIA—breast cancer	4.93e-07	0.000314	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOTCH1—breast cancer	4.9e-07	0.000312	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOTCH1—breast cancer	4.89e-07	0.000311	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KIT—breast cancer	4.79e-07	0.000305	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PIK3CG—breast cancer	4.79e-07	0.000305	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APC—breast cancer	4.79e-07	0.000305	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APC—breast cancer	4.78e-07	0.000304	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PIK3CG—breast cancer	4.78e-07	0.000304	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KIT—breast cancer	4.78e-07	0.000304	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EGF—breast cancer	4.74e-07	0.000302	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EGF—breast cancer	4.72e-07	0.000301	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—MAPK3—breast cancer	4.59e-07	0.000292	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—MAPK3—breast cancer	4.58e-07	0.000291	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—BRAF—breast cancer	4.51e-07	0.000287	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—BRAF—breast cancer	4.49e-07	0.000286	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1—breast cancer	4.39e-07	0.000279	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT2—breast cancer	4.39e-07	0.000279	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1—breast cancer	4.37e-07	0.000279	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT2—breast cancer	4.37e-07	0.000278	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EGFR—breast cancer	4.37e-07	0.000278	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EGFR—breast cancer	4.35e-07	0.000277	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PIK3CD—breast cancer	4.21e-07	0.000268	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PIK3CD—breast cancer	4.2e-07	0.000267	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	4.17e-07	0.000266	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SERPINE1—breast cancer	4.17e-07	0.000265	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	4.16e-07	0.000265	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SERPINE1—breast cancer	4.15e-07	0.000265	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—KRAS—breast cancer	4.13e-07	0.000263	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—KRAS—breast cancer	4.11e-07	0.000262	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOS3—breast cancer	3.98e-07	0.000253	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOS3—breast cancer	3.97e-07	0.000253	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	3.79e-07	0.000241	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	3.78e-07	0.000241	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MDM2—breast cancer	3.77e-07	0.00024	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MDM2—breast cancer	3.76e-07	0.00024	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RAF1—breast cancer	3.76e-07	0.00024	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RAF1—breast cancer	3.75e-07	0.000239	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RELA—breast cancer	3.74e-07	0.000239	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RELA—breast cancer	3.73e-07	0.000238	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ERBB2—breast cancer	3.72e-07	0.000237	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ERBB2—breast cancer	3.71e-07	0.000236	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PIK3CB—breast cancer	3.67e-07	0.000234	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MTOR—breast cancer	3.67e-07	0.000234	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MTOR—breast cancer	3.66e-07	0.000233	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	3.66e-07	0.000233	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL8—breast cancer	3.53e-07	0.000225	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL8—breast cancer	3.52e-07	0.000224	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HRAS—breast cancer	3.51e-07	0.000223	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HRAS—breast cancer	3.5e-07	0.000223	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CDKN1B—breast cancer	3.45e-07	0.00022	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	3.44e-07	0.000219	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT1—breast cancer	3.41e-07	0.000217	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	3.4e-07	0.000216	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CASP3—breast cancer	3.38e-07	0.000215	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL2—breast cancer	3.37e-07	0.000215	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CASP3—breast cancer	3.37e-07	0.000214	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL2—breast cancer	3.36e-07	0.000214	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6—breast cancer	3.36e-07	0.000214	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6—breast cancer	3.35e-07	0.000213	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCND1—breast cancer	3.29e-07	0.000209	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—JUN—breast cancer	3.28e-07	0.000209	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCND1—breast cancer	3.28e-07	0.000209	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JUN—breast cancer	3.27e-07	0.000208	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CTNNB1—breast cancer	3.26e-07	0.000207	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	3.25e-07	0.000207	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP9—breast cancer	3.19e-07	0.000203	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP9—breast cancer	3.18e-07	0.000203	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CDKN1A—breast cancer	3.18e-07	0.000203	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PTEN—breast cancer	3.17e-07	0.000202	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	3.17e-07	0.000202	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PTEN—breast cancer	3.16e-07	0.000201	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK8—breast cancer	3.1e-07	0.000198	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT1—breast cancer	3.1e-07	0.000197	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK8—breast cancer	3.09e-07	0.000197	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT1—breast cancer	3.09e-07	0.000197	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SRC—breast cancer	2.94e-07	0.000187	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SRC—breast cancer	2.93e-07	0.000187	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.87e-07	0.000183	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VEGFA—breast cancer	2.86e-07	0.000182	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—STAT3—breast cancer	2.84e-07	0.000181	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—STAT3—breast cancer	2.83e-07	0.00018	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK3—breast cancer	2.71e-07	0.000173	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.7e-07	0.000172	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MYC—breast cancer	2.64e-07	0.000168	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TGFB1—breast cancer	2.63e-07	0.000168	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MYC—breast cancer	2.63e-07	0.000167	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.62e-07	0.000167	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EGFR—breast cancer	2.58e-07	0.000164	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EGFR—breast cancer	2.57e-07	0.000164	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KRAS—breast cancer	2.44e-07	0.000155	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KRAS—breast cancer	2.43e-07	0.000155	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PIK3CA—breast cancer	2.24e-07	0.000143	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.23e-07	0.000142	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TP53—breast cancer	2.17e-07	0.000138	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TP53—breast cancer	2.16e-07	0.000137	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HRAS—breast cancer	2.07e-07	0.000132	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HRAS—breast cancer	2.06e-07	0.000131	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6—breast cancer	1.98e-07	0.000126	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6—breast cancer	1.98e-07	0.000126	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT1—breast cancer	1.83e-07	0.000116	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT1—breast cancer	1.82e-07	0.000116	CbGpPWpGaD
